Intraocular Pressure

Recent data showed a greater incidence of ocular surface disease symptoms in patients receiving medical treatment for glaucoma, according to a study published in Clinical Ophthalmology.

Both iStent implantation and Kahook Dual Blade goniotomy are effective in combination with cataract surgery to reduce IOP in patients with open-angle glaucoma, according to a study.

Sildenafil, a phosphodiesterase type 5 inhibitor, could be used to treat ocular hypotension or postsurgical shallow anterior chamber, according to a presentation at the virtual Association for Research in Vision and Ophthalmology meeting.

The FDA has accepted the premarket approval application for Santen Pharmaceutical’s DE-128 microshunt for review, according to a press release.

The Xen45 gel stent showed promising short-term safety and efficacy in patients with refractory glaucoma, according to a poster presented at the virtual Association for Research in Vision and Ophthalmology meeting.

In this video perspective, E. Randy Craven, MD, associate professor of ophthalmology at Wilmer Eye Institute-Bethesda, discusses his regimen for implanting the Durysta (bimatoprost implant) from Allergan.

Secondary analysis of the LiGHT trial showed that patients treated first with medications were more likely to undergo rapid visual field progression than those treated first with selective laser trabeculoplasty.

When treated first with selective laser trabeculoplasty, ocular hypertensive and glaucoma patients may see a delay in visual field progression when compared to initial medical therapy, according to study results.

The OTX-TP travoprost insert showed durable IOP-lowering effect over 12 weeks and a low incidence of the commonly reported side effects of travoprost drops.

Two-year interim outcomes of the PALADIN study showed that sustained, continuous release of fluocinolone acetonide through the Iluvien implant resulted in significant reduction of mean central subfoveal thickness in diabetic macular edema.